在基于滋养层的NK细胞培养中,Brand A无血清培养基无法支持NK细胞有效增殖,而HIPP-T009 在完全无血清条件下即可实现NK细胞高效扩增,甚至其NK细胞扩增效率显著优于添加5%血清的Brand A培养基,Day 14扩增倍数提升了27%。流式结果显示HIPP-T009中CD3-/CD56+比例为68.9%,与含血清培养相当。

 

 

(1)Guan, X.; Bu, F.; Fu, Y.; Zhang, H.; Xiang, H.; Chen, X.; Chen, T.; Wu, X.; Wu, K.; Liu, L.; Dong, X. Immunogenic Peptides Putatively from Intratumor Microbes: Opportunities for Colorectal Cancer Treatment. iScience 2024, 27 (12), 111338. https://doi.org/10.1016/j.isci.2024.111338.

(2)Si, W.; Cheng, S.; He, H.; Zhang, Y.; Miao, Y.; Yi, D.; Ni, M.; Wang, A.; Fan, H.; Bo, Y.; Liu, C.; Bu, Z.; Zhu, L.; Zhang, Z. SARDH in the 1-C Metabolism Sculpts the T-Cell Fate and Serves as a Potential Cancer Therapeutic Target. Cell Mol Immunol 2025, 22 (11), 1363–1378. https://doi.org/10.1038/s41423-025-01331-5.

(3)Xiang, H.; Guan, X.; Wei, Y.; Luo, S.; Zhang, H.; Bu, F.; Yan, Y.; Fu, Y.; Li, Y.; Xu, Q.; Lin, P.; Liu, D.; Zhou, X.; Gao, F.; Chen, T.; Nie, G.; Wu, K.; Gu, Y.; Liu, L.; Ye, Z.; Wu, X.; Zhao, R.; Liu, S.; Dong, X. Predominant Mutated Non-Canonical Tumor-Specific Antigens Identified by Proteogenomics Demonstrate Immunogenicity and Tumor Suppression in CRC. Cell Genom 2025, 101062. https://doi.org/10.1016/j.xgen.2025.101062.